華富財經 Quamnet.com Logo
新聞
2020-07-02 15:18:54
CRMI (08158) FY19 loss reduced to HK$395.01M

(Infocast News) Audited results of China Regenerative Medicine International Limited (08158) for the fiscal year ended 31 December 2019:

Net loss: HK$395.006M (HK$1.1935B net loss for the same period last year)

Basic LPS: HK$0.449

Dividend per share proposed: (Nil)

(WL)